Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increased investment and commitment to malaria prevention and treatment strategies across Africa has produced impressive reductions in the incidence of this disease. Nevertheless, it is clear that further interventions will be necessary to meet the international target of a reversal in the incidence of malaria by 2015. This article discusses the prospective role of an innovative malaria control strategy - the community-based treatment of asymptomatic carriers of Plasmodium falciparum, with artemisinin-based combination therapy (ACT). The potential of this intervention was considered by key scientists in the field at an Advisory Board meeting held in Basel, in April 2009. This article summarizes the discussions that took place among the participants. PRESENTATION OF THE HYPOTHESIS: Asymptomatic carriers do not seek treatment for their infection and, therefore, constitute a reservoir of parasites and thus a real public-health risk. The systematic identification and treatment of individuals with asymptomatic P. falciparum as part of a surveillance intervention strategy should reduce the parasite reservoir, and if this pool is greatly reduced, it will impact disease transmission. TESTING THE HYPOTHESIS: This article considers the populations that could benefit from such a strategy and examines the ethical issues associated with the treatment of apparently healthy individuals, who represent a neglected public health risk. The potential for the treatment of asymptomatic carriers to impair the development of protective immunity, resulting in a 'rebound' and age escalation of malaria incidence, is also discussed.For policymakers to consider the treatment of asymptomatic carriers with ACT as a new tool in their malaria control programmes, it will be important to demonstrate that such a strategy can produce significant benefits, without having a negative impact on the efficacy of ACT and the health of the target population. IMPLICATIONS OF THE HYPOTHESIS: The treatment of asymptomatic carriers with ACT is an innovative and essential tool for breaking the cycle of infection in some transmission settings. Safe and effective medicines can save the lives of children, but the reprieve is only temporary so long as the mosquitoes can become re-infected from the asymptomatic carriers. With improvements in rapid diagnostic tests that allow easier identification of asymptomatic carriers, the elimination of the pool of parasites is within reach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The economic and social burden of malaria
Sachs, J., & Malaney, P. (2002) · Nature · doi:10.1038/415680a · Cited by 2,248 · cited 1×
“Recent work has demonstrated the pervasive effect of malaria on a country’s socioeconomic situation [31].”
Haas, J. D., & Brownlie, T. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.676s · Cited by 1,186
Bhattarai, A., Ali, A. S., Kachur, S. P., Mårtensson, A., Abbas, A. K., Khatib, R., Al-mafazy, A.-W., Ramsan, M., Rotllant, G., Gerstenmaier, J. F., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040309 · Cited by 647 · cited 1×
“In Rwanda, Ethiopia, and Zanzibar, the mass distribution of insecticide-treated bed nets (ITNs), coupled with increasing use of long-lasting ITNs and nationwide adoption of artemisinin-based combination therapy (ACT), resulted in substantial declines in malaria-related deaths [1,2].”
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis
Ceesay, S. J., Casals-Pascual, C., Erskine, J., Anya, S. E., Duah, N. O., Fulford, A. J., Sesay, S. S., Abubakar, I., Dunyo, S., Sey, O., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61654-2 · Cited by 425
Iron treatment normalizes cognitive functioning in young women
Murray-Kolb, L. E., & Beard, J. L. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.778 · Cited by 373 · cited 1×
“Anaemia has been related to reduced work capacity [36], poor pregnancy outcomes [37], and reduced cognitive function [38].”
SEVEN YEARS OF REGIONAL MALARIA CONTROL COLLABORATION—MOZAMBIQUE, SOUTH AFRICA, AND SWAZILAND
SHARP, B. L., KLEINSCHMIDT, I., STREAT, E., MAHARAJ, R., BARNES, K. I., DURRHEIM, D. N., RIDL, F. C., MORRIS, N., SEOCHARAN, I., KUNENE, S., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.42 · Cited by 269 · cited 1×
“Similarly, interventions to increase the coverage of ITNs in The Gambia and to improve vector control through a programme of indoor residual spraying (IRS) in South Africa have both produced marked reductions in confirmed malaria cases [3,4].”
Otten, M., Aregawi, M., Were, W., Karema, C., Medin, A., Bekele, W., Jima, D., Gausi, K., Komatsu, R., Korenromp, E., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-14 · Cited by 230
Bell, D. J., Wootton, D., Mukaka, M., Montgomery, J., Kayange, N., Chimpeni, P., Hughes, D. A., Molyneux, M. E., Ward, S. A., Winstanley, P. A., et al. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-204 · Cited by 76
Rahman, M. M., Dondorp, A. M., Day, N. P. J., Lindegardh, N., Imwong, M., Faiz, M. A., Bangali, A. M., Kamal, A. T. M. M., Karim, J., Kaewkungwal, J., et al. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.05.022 · Cited by 54 · cited 1×
“Notably, excellent adherence to the artemether-lumefantrine treatment regimen during clinical malaria has been reported [39,40].”
Cited by
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
The complexities of malaria disease manifestations with a focus on asymptomatic malaria
Laishram, D. D., Sutton, P. L., Nanda, N., Sharma, V. L., Sobti, R. C., Carlton, J. M., & Joshi, H. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-29 · Cited by 340
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Tiono, A. B., Ouédraogo, A., Ogutu, B., Diarra, A., Coulibaly, S., Gansané, A., Sirima, S. B., O’Neil, G., Mukhopadhyay, A., & Hamed, K. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-79 · Cited by 118
“However, as they do not seek treatment for their infection, asymptomatic carriers can have high levels of gametocytes [1] and constitute an important parasite reservoir available for infection of newly hatched mosquitoes [4,5].”
BackgroundSelf-citationLarsen, D. A., Bennett, A., Silumbe, K., Hamainza, B., Yukich, J. O., Keating, J., Littrell, M., Miller, J. M., Steketee, R. W., & Eisele, T. P. (2015) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0347 · Cited by 108
“With renewed emphasis on malaria elimination, the expansion of antimalarial drug use to clear infections from people regardless of symptoms or treatment-seeking behavior is regarded as a potential tool.(3) In addition to clinical malaria cases, asymptomatic malaria infections likely play a significant role in malaria…”
BackgroundAdvances in molecular diagnosis of malaria
(2017) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2016.11.006 · Cited by 41
Metadata
- Authors
- Ogutu, B., Tiono, A. B., Makanga, M., Premji, Z., Gbadoé, A. D., Ubben, D., Marrast, A. C., & Gaye, O.
- Venue
- Malaria Journal
- Published
- 2010-01-22
- Volume
- 9
- Issue
- 1
- Pages
- 30-30
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W1975377767
- Cited by
- 58
- References
- 9
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.